Cargando…
CTLA4-Ig treatment prevents murine experimental autoimmune encephalomyelitis
Autores principales: | Cross, A.H., Girard, T.J., Giacoletto, K.S., Evans, R.J., Karr, R.W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119817/ http://dx.doi.org/10.1016/0165-5728(94)90286-0 |
Ejemplares similares
-
Histamine and neuroinflammation: insights from murine experimental autoimmune encephalomyelitis
por: Passani, Maria B., et al.
Publicado: (2012) -
Redundancy between Cysteine Cathepsins in Murine Experimental Autoimmune Encephalomyelitis
por: Allan, Euan Ramsay Orr, et al.
Publicado: (2015) -
IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis
por: Benkhoucha, Mahdia, et al.
Publicado: (2012) -
Essential Role of NK Cells in IgG Therapy for Experimental Autoimmune Encephalomyelitis
por: Chong, Wai Po, et al.
Publicado: (2013) -
CTLA-4 Modulates the Differentiation of Inducible Foxp3(+) Treg Cells but IL-10 Mediates Their Function in Experimental Autoimmune Encephalomyelitis
por: Verhagen, Johan, et al.
Publicado: (2014)